RadNet SEC Filings

Type
Report
Date
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/30/2026
424B7424B7-Formular1/30/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/9/2026
4Insidertransaktion12/12/2025
4Insidertransaktion12/12/2025
4Insidertransaktion12/9/2025
144144-Formular12/5/2025
4Insidertransaktion12/5/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben12/4/2025
424B7424B7-Formular12/4/2025
S-3ASRS-3ASR-Formular12/4/2025
4Insidertransaktion12/3/2025
4Insidertransaktion11/28/2025
4Insidertransaktion11/21/2025
4Insidertransaktion11/19/2025
144144-Formular11/19/2025
144144-Formular11/19/2025
144144-Formular11/19/2025
4Insidertransaktion11/17/2025
10-QQuartalsbericht11/10/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/10/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/21/2025
424B7424B7-Formular10/21/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular10/17/2025
4Insidertransaktion9/18/2025
4Insidertransaktion9/17/2025
144144-Formular9/16/2025
4Insidertransaktion9/15/2025
144144-Formular9/15/2025
4Insidertransaktion9/12/2025
4Insidertransaktion9/12/2025
144144-Formular9/11/2025
4Insidertransaktion9/10/2025
144144-Formular9/10/2025
144144-Formular9/9/2025
144144-Formular8/29/2025
4Insidertransaktion8/29/2025
4Insidertransaktion8/21/2025
4Insidertransaktion8/21/2025
144144-Formular8/15/2025
4Insidertransaktion8/15/2025
10-QQuartalsbericht8/11/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/11/2025
EFFECTEFFECT-Formular7/29/2025
S-8S-8-Formular7/22/2025
POS AMPOS AM-Formular7/22/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/17/2025
4Insidertransaktion6/18/2025
144144-Formular6/12/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben6/12/2025
4Insidertransaktion6/11/2025
4Insidertransaktion6/11/2025
4Insidertransaktion6/11/2025
4Insidertransaktion6/11/2025
144144-Formular6/9/2025
4Insidertransaktion6/6/2025
144144-Formular6/5/2025
4Insidertransaktion6/3/2025
4Insidertransaktion5/27/2025
144144-Formular5/23/2025
144144-Formular5/22/2025
EFFECTEFFECT-Formular5/21/2025
424B3424B3-Formular5/21/2025
4Insidertransaktion5/20/2025
4Insidertransaktion5/20/2025
S-4/AS-4/A-Formular5/19/2025
CORRESPCORRESP-Formular5/19/2025
144144-Formular5/16/2025
144144-Formular5/16/2025
4Insidertransaktion5/15/2025
144144-Formular5/15/2025
144144-Formular5/15/2025
UPLOADUPLOAD-Formular5/13/2025
425425-Formular5/13/2025
425425-Formular5/12/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/12/2025
10-QQuartalsbericht5/12/2025
S-4S-4-Formular5/6/2025
4Insidertransaktion5/2/2025
425425-Formular4/29/2025
DEFA14ADEFA14A-Formular4/28/2025
ARSARS-Formular4/28/2025
DEF 14ADEF 14A-Formular4/28/2025
10-K/A10-K/A-Formular4/28/2025
425425-Formular4/24/2025
425425-Formular4/24/2025
425425-Formular4/17/2025
425425-Formular4/17/2025
425425-Formular4/17/2025
425425-Formular4/17/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025

RadNet Documents 2026

This page contains all official documents and SEC filings for RadNet stock (RDNT, ISIN: US7504911022). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of RadNet's regulatory filings.

RadNet Stock analysis

RadNet RadNet Inc is a leading company in the field of diagnostic imaging in the United States. The company was founded in 1985 and has since undergone impressive development. Today, RadNet operates the largest network of diagnostic imaging centers in the United States and offers a comprehensive range of diagnostic and therapeutic procedures. RadNet's business model is focused on providing high-quality diagnostic imaging services at competitive prices. The company generates most of its revenue by providing imaging services to Medicare patients and private patients funded by insurers and employers. RadNet also offers its services directly to healthcare facilities, including physician practices, hospitals, and clinics. RadNet offers a wide range of diagnostic imaging services, including X-rays, CT scans, MRI scans, and nuclear medicine procedures. The company also offers specialized imaging services, including mammography, ultrasound, and PET-CT. RadNet, along with its partners, also provides radiation therapy and other cancer treatments. In recent years, RadNet has also experienced strong development in the field of telemedicine and artificial intelligence (AI). An AI-based image processing platform has been developed to assist in the detection of cancer and other diseases. The platform uses innovative algorithms to read and analyze imaging results faster and more accurately. The company has also conducted a series of acquisitions in recent years to strengthen its position in the field of diagnostic imaging. In 2017, the company acquired Doshi Diagnostics Imaging Services, which operated in New York City. In 2018, the company entered into a long-term partnership with Florida-based Diagnostic Centers of America (DCA), and in 2020, the company acquired Elite Imaging of South Florida LLC. These acquisitions have helped RadNet strengthen its presence in core markets and expand its reach into new areas. RadNet has also made a name for itself by developing innovative technology and new models of collaboration. The company has a firm place in the healthcare and research world, working together with respected health systems, academies, and universities to find new ways to diagnose and treat diseases. In summary, RadNet Inc is a leading company in the field of diagnostic imaging. The company offers high-quality and innovative services tailored to the needs of patients, physicians, and healthcare facilities. RadNet remains committed to achieving the best possible outcomes for its customers and further expanding its position in the market.